18546626

Source:http://linkedlifedata.com/resource/pubmed/id/18546626

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013203, umls-concept:C1140680, umls-concept:C1555029
pubmed:dateCreated	2008-6-12
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0121103
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status	MEDLINE
pubmed:issn	0065-2598
pubmed:author	pubmed-author:AngJoo ErnJE, pubmed-author:KayeStan BSB, pubmed-author:TanDavid S PDS
pubmed:issnType	Print
pubmed:volume	622
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	153-67
pubmed:meshHeading	pubmed-meshheading:18546626-Animals, pubmed-meshheading:18546626-Antineoplastic Agents, pubmed-meshheading:18546626-Clinical Trials as Topic, pubmed-meshheading:18546626-Drug Resistance, Neoplasm, pubmed-meshheading:18546626-Female, pubmed-meshheading:18546626-Humans, pubmed-meshheading:18546626-Ovarian Neoplasms
pubmed:year	2008
pubmed:articleTitle	Ovarian cancer: can we reverse drug resistance?
pubmed:affiliation	Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK.
pubmed:publicationType	Journal Article, Review